Related content

¹⁸F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

By Eschmann Susanne   Friedel Godehard   Paulsen Frank   Reimold Matthias   Hehr Thomas   Budach Wilfried   Langen Heinz-Jakob   Bares Roland  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 463-471

Springer Publishing Company

Access to resources Recommend Favorite

Value of FDG-PET in the management of non-small cell lung cancer

By Stroobants S.   Verschakelen J.   Vansteenkiste J.  

European Journal of Radiology, Vol. 45, Iss. 1, 2003-01 ,pp. : 49-59

Elsevier

Access to resources Recommend Favorite

Impact of [¹⁸F]FDG-PET on the primary staging of small-cell lung cancer

By Brink I.   Schumacher T.   Mix M.   Ruhland S.   Stoelben E.   Digel W.   Henke M.   Ghanem N.   Moser E.   Nitzsche E.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1614-1620

Springer Publishing Company

Access to resources Recommend Favorite

FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation

By Shim Sung  

Annals of Nuclear Medicine, Vol. 24, Iss. 5, 2010-06 ,pp. : 357-362

Springer Publishing Company

Access to resources Recommend Favorite

Target volume definition for ¹⁸F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer

By Nestle Ursula   Schaefer-Schuler Andrea   Kremp Stephanie   Groeschel Andreas   Hellwig Dirk   Rübe Christian   Kirsch Carl-Martin  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 453-462

Springer Publishing Company

Access to resources Recommend Favorite